Who
Dennis M. McGrath
Director
Company insider
Files Form 4 as: Director, DarioHealth; President and CFO, PAVmed; Chief Financial Officer, Lucid Diagnostics; Director, Citius Oncology; Director, Citius Pharmaceuticals; President & CFO, FC Global Realty.
In numbers
- Trades disclosed
- 116
- Buys
- 7
- Sells
- 10
- Bought
- $67K
- Sold
- $3.6M
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 15 Jan 2006
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —61,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —61,000 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —470,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —470,000 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 19 Sep 2025filed 22 Dec 2025 | CTOR Citius OncologyBiotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 19 Sep 2025filed 1 Dec 2025 | CTOR Citius OncologyBiotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 19 Sep 2025filed 23 Sep 2025 | CTOR Citius OncologyBiotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 Feb 2025filed 21 Feb 2025 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 12 Dec 2024filed 16 Dec 2024 | CTOR Citius Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 7 Nov 2024filed 12 Nov 2024 | CTXR Citius Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | CTOR Citius Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 7 May 2024filed 8 May 2024 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 6 Mar 2024filed 8 Mar 2024 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 10 Oct 2023filed 12 Oct 2023 | CTXR Citius Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 7 Feb 2023filed 9 Feb 2023 | CTXR Citius Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 21 Dec 2022filed 23 Dec 2022 | DRIO DarioHealthMedical Devices | SEC FORM 4 Sold | $39K9,872 at $3.97 | filing |
News
No headline names them, or the companies they trade most, lately.